TWA
AXSM icon

TCI Wealth Advisors’s Axsome Therapeutics AXSM Stock Holding History

TCI Wealth Advisors’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-108
Closed -$6.66K – 397
2023
Q1 		$6.66K Buy
108
+39
+57% +$2.56K ﹤0.01% 1334
2022
Q4 		$5.32K Buy
+69
New +$4.12K ﹤0.01% 1483
2022
Q2 		– Sell
-123
Closed -$5K – 2274
2022
Q1 		$5K Hold
123
– – ﹤0.01% 1498
2021
Q4 		$5K Buy
123
+41
+50% +$1.51K ﹤0.01% 1623
2021
Q3 		$3K Buy
82
+25
+44% +$974 ﹤0.01% 1902
2021
Q2 		$4K Buy
57
+22
+63% +$1.32K ﹤0.01% 1530
2021
Q1 		$2K Buy
+35
New +$2.46K ﹤0.01% 1669

Other funds holding AXSM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return